ArticlePDF Available

New Insights on Dimethylaminoethanol (DMAE) Features as a Free Radical Scavenger



Recently, a number of synthetic drugs used in a variety of therapeutic indications have been reported to have antiaging effects. Among them, Dimethylaminoethanol (DMAE), an anologue of dietylaminoethanol, is a precursor of choline, which in turn allows the brain to optimize the production of acetylcholine that is a primary neurotransmitter involved in learning and memory. The data presented here includes new information on the ability of the compound to scavenge specific free radicals, assessed by Electron Spectroscopic Resonance (EPR), to further analyze the role of DMAE as an antioxidant. DMAE ability to directly react with hydroxyl, ascorbyl and lipid radicals was tested employing in vitro assays, and related to the supplemented dose of the compound.
54 Drug Metabolism Letters, 2012, 6, 54-59
1874-0758/12 $58.00+.00 ©2012 Bentham Science Publishers
New Insights on Dimethylaminoethanol (DMAE) Features as a Free
Radical Scavenger
Gabriela Malanga1, María Belén Aguiar1, Hugo D. Martinez2 and Susana Puntarulo1,*
1Physical Chemistry-PRALIB, School of Pharmacy and Biochemistry, University of Buenos Aires-CONICET, Buenos Aires,
Argentina; 2Pharmaceutical Technology Department, School of Pharmacy and Biochemistry, University of Buenos
Aires-CONICET, Buenos Aires, Argentina
Abstract: Recently, a number of synthetic drugs used in a variety of therapeutic indications have been reported to have
antiaging effects. Among them, Dimethylaminoethanol (DMAE), an anologue of dietylaminoethanol, is a precursor of
choline, which in turn allows the brain to optimize the production of acetylcholine that is a primary neurotransmitter
involved in learning and memory. The data presented here includes new information on the ability of the compound to
scavenge specific free radicals, assessed by Electron Spectroscopic Resonance (EPR), to further analyze the role of
DMAE as an antioxidant. DMAE ability to directly react with hydroxyl, ascorbyl and lipid radicals was tested employing
in vitro assays, and related to the supplemented dose of the compound.
Keywords: Dimethylaminoethanol (DMAE), antioxidant, ascorbyl radical, hydroxyl radical, lipid radicals.
Recently, a number of synthetic drugs used in a variety of
therapeutic indications have been reported to have antiaging
effects. Among them, Dimethylaminoethanol (DMAE), an
anologue of dietylaminoethanol, allows the brain to optimize
learning and memory [1]. DMAE, that is a naturally
occurring nutrient found in food such as anchovies and
sardines, is used in the treatment of panic attack, in problems
related to behavior and learning, mainly in children with
hiperactivity and attention deficit, in chronic fatigue, in light
depression syndrome, to improve the dream quality [2], on
periorbital oedema (swelling of the eyelids) and on skin
tightness [3]. It was also reported that DMAE administration
to rats inhibits the formation of the aging pigment (lipofuscin)
and flushes it from the body. Lipofuscin is believed to be
formed by free radical reactions on the inefficient meta-
bolism of fatty acids, and it accumulates with age in all body
tissues. DMAE also seems to limit other aging symptoms in
brain and heart muscle [4]. Free radical scavengers and
antioxidants can reduce lipid peroxidation and the generation
of reactive oxygen species (ROS). Live cells continuously
produce low amounts of ROS like superoxide anion (O2-)
and hydrogen peroxide (H2O2) as by-products of aerobic
metabolism. The H2O2 is further involved with transition
metals through the Fenton reaction forming highly reactive
hydroxyl radicals (OH) [5]. Moreover, some cellular
constituents like ascorbate (AH-) can reduce oxidized Fe3+ to
Fe2+ generating catalytically active Fe that fuels OH and
ascorbyl radical (A) formation. Also, unsaturated membrane
lipids can generate radical species like peroxyl (ROO), alkoxyl
(RO) and alkyl (R) radicals by reactions catalyzed by Fe.
*Address correspondence to this author at the Fisicoquímica, Facultad de
Farmacia y Bioquímica, Junín 956, 1113 Buenos Aires, Argentina;
Tel: (54-11) 4964-8244; Fax: (54-11) 4508-3646;
Electron Paramagnetic Resonance (EPR), also known as
Electron Spin Resonance (ESR) is, at present, the only
analytical approach that permits the direct detection of free
radicals. This technique reports on the magnetic properties of
unpaired electrons and their molecular environment. The
electron spin resonance spectral lines have shape, width,
intensity and position (g-value), and hyperfine spectral
line splitting from the interaction of unpaired electrons
with magnetic nuclei that can determine the structure or
positions of free radical components. Biologically important
paramagnetic species include free radicals and many
transition elements. In view of the interest in the use
and characterization of natural and synthetic compounds,
the antioxidant properties of many products, including
commercially available dietary supplements from wheat
bran, gingko biloba (EGb) and alfalfa extracts [6, 7] were
compared. Therefore, EPR techniques allow the specific
identification of the antioxidant potential of a compound, or
a mix of compounds under analysis. Moreover, over the past
decade the interest in A metabolism in biological systems
has been growing and the EPR detectable concentration of
A has been interpreted as a reflection of the ongoing free
radical flux in the studied system [8]. Thus, EPR techniques
might be used for the determination of free radical
generation rate and content in biological and chemical
systems, besides analyzing the capacity of a product to
scavenge an individual reactive species.
The hypothesis of this work was that the commercially
available DMAE has antioxidant properties. To analyze the
mechanisms of DMAE to exert its capacity as scavenger,
spin trapping and direct EPR spectroscopy were used to
get evidence for reduction of radical intermediates of
lipid peroxidation and hydrophilic radicals. The ability of
DMAE to inhibit rat liver microsomal NADPH-dependent
lipid peroxidation (lipid radicals), and OH, and chemical
generation of A radicals was studied.
New Insights on Dimethylaminoethanol (DMAE) Drug Metabolism Letters, 2012, Vol. 6, No. 1 55
DMAE Bitartrate salt (2-dimethylaminoethanol), a
synthetic drug with therapeutic use (Fig. 1), was obtained
from Saporiti Chemical Co S.A.C.I.F.I.A., Argentina with
Analytical Certification Number 2654 (set DB 909). DMAE
is not an approved additive in the USA nor is an orphan
Fig. (1). DMAE chemical structure.
Thiobarbituric Acid Reactive Substances (TBARS)
TBARS was measured using a modified fluorescence
method [6]. Rat liver microsomes were supplemented with
0.1 mM NADPH, 50 μM Fe-EDTA (1:2), in 100 mM
potassium phosphate buffer (pH 7.4) and incubated during
20 min at 37ºC in the presence or absence of aliquots of
DMAE. To 0.5 ml of reaction medium, 0.05 ml of 4% (w/v)
BHT and 0.2 ml of 3% (w/v) sodium dodecyl sulfate were
added. After mixing, 2 ml of 0.1 N HCl, 0.3 ml of 10% (w/v)
phosphotungstic acid, and 1 ml of 0.7% (w/v) 2-
thiobarbituric acid was added. The mixture was heated for 45
min in boiling water, and TBARS were extracted into 5 ml
of n-butanol. After a brief centrifugation, the fluorescence
of the butanol layer was measured at excit=515 nm
and emis=555 nm. The values were expressed as nmol
TBARS (malondialdehyde equivalents) per mg of protein.
Malondialdehyde standards were prepared from 1,1,3,3-
Lipid Radicals Generation Determined by EPR-spin
Rat liver microsomes were prepared in -phenyl-tert-N-
butyl-nitrone (PBN). EPR spectra were obtained at room
temperature using a Bruker Espectrometer ECS 106,
operating at 9.75 GHz with 50 kHz modulation frequency.
EPR instrument settings for the spin trapping experiments
were: microwave power, 20 mW; modulation amplitude,
1.232 G; time constant, 81.92 ms; receiver gain, 2 x 104 [8].
Quantitation of the spin adduct was performed using an
aqueous solution of 2,2,5,5-tetramethyl piperidine 1-oxyl
(TEMPO) introduced into the same sample cell used for spin
trapping. EPR spectra for both sample and TEMPO solutions
were recorded at exactly the same spectrometer settings and
the first derivative EPR spectra were double-integrated to
obtain the area intensity, then the concentration of spin
adduct was calculated according to Kotake et al. [9].
OH Production Determined by EPR-spin Trapping
Prior to use, DMPO was purified, following the method
of Green and Hill [10], to remove contaminants that
contribute to EPR background signal. In this procedure, 10
ml of 1 mM DMPO in doubly distilled water are mixed with
1.25 g activated charcoal for 1 min, allowed to stand for 1 h,
and then filtered. This purification procedure was repeated
twice. The basic microsomal incubation system consisted of
100 mM DMPO, microsomes (1 mg protein/ml), 0.5 mM
sodium azide, 0.6 mM DTPA, and 50 mM potassium
phosphate (pH 7.4). Reactions were started by addition of
0.5 mM NADPH. The microsomal reaction system was
transferred to a Pasteur pipette for direct observation of the
reaction in a Bruker ECS 106 EPR spectrometer at room
temperature. The EPR spectrometer settings were as follows:
microwave power, 20 mW; modulation amplitude, 0.490 G;
time constant, 655.36 ms; field scan, 100 G; scan time,
167.772 s; and modulation frequency 50 kHz [11].
Detection of A
A Bruker ECS 106 spectrometer was used for A
measurements. Ascorbic acid (60 μM) in the presence of 50
μM Fe-EDTA (1:2) was supplemented with dimethylsulfoxide
(DMSO) and the spectra were immediately scanned in the
following conditions: 50 kHz field modulation, room
temperature, microwave power 10 mW, modulation
amplitude 1 G, time constant 655 ms, receiver gain 1 x 105,
microwave frequency 9.81 GHz, and scan rate 0.18 G/s [12].
Quantification was performed as previously described,
according to Kotake et al. [9].
Statistical Analysis
Data in the text, figures and tables are expressed as
means ± SEM of 3 to 6 independent experiments. Statistical
tests were carried out using Statview for Windows, ANOVA,
SAS Institute Inc., version 5.0.
Peroxidation of rat liver microsomes was studied in the
presence of Fe-EDTA as the Fe catalyst and NADPH as the
reductant for the microsomal electron transfer system.
Production of TBARS exhibited a linear time course for 20-
25 min (data not shown). Supplementation of DMAE in the
concentration range of 0 to 4.2 M, did not show any
significant inhibitory effect on TBARS production by rat
liver microsomes. Since lipid peroxidation seems as the
biochemical process leading to the appearance of lipofuscin
that was reported as decreased in the tissues supplemented
with DMAE, a more sensitive and specific method, EPR,
was used to study this effect. The decomposition of hydro-
peroxides formed during NADPH-dependent peroxidation in
rat liver microsomes supplemented with Fe led to the
generation of lipid radicals, such as ROO, RO and R
radicals, that combined with the spin trap PBN resulted in
adducts that gave a characteristic EPR spectrum with
hyperfine coupling constants of aN=15.8 G and aH=2.6 G
(Fig. 2A c), in agreement with computer spectral simulated
signals obtained using those parameters (Fig. 2A a). Even
though these constants could be assigned to lipid radicals,
spin trapping studies cannot readily distinguish between
ROO, RO and R adducts, owing to the similarity of the
corresponding coupling constants [13]. In the absence of
56 Drug Metabolism Letters, 2012, Vol. 6, No. 1 Malanga et al.
microsomes no EPR signal was observed (Fig. 2A b). The
addition of the tested drug exhibited a maxima scavenging
activity, reducing the PBN-adduct signal by 44% (Fig. 2A d)
in the presence of 2 M of the substance in comparison with
the control sample without the drug addition, which
represents 100% PBN-lipid radical adduct (Fig. 2A c). The
results presented here are consistent with the hypothesis that
indicates that lipid radicals are quenched by DMAE
Rat liver microsomes in the presence of DMPO, NADPH
and Fe-EDTA generate an EPR spectra (Fig. 3A c) with the
parameters characteristics of the DMPO-OH spin adduct
(aN=15 G and aH=15 G), according to computer simulation
records [14] (Fig. 3A a). In the absence of microsomes no
EPR signal was observed (Fig. 3A b). The basic system,
without the addition of any scavenger, which represents
100% DMPO-OH radical adduct showed an steady state
concentration of 4.5 ± 0.1 μM. The addition of the tested
Fig. (2). Scavenging ability of DMAE against lipid radicals. A. EPR spectra of the lipid radical-PBN spin adduct, (a) computer simulated
spectrum employing as spectral parameters aN=15.8 G and aH=2.6 G and g= 2.005; (b) and basal system (in the absence of microsomes); (c)
lipid radical-PBN spin adduct generated in rat liver microsomes; (d) lipid radical-PBN spin adduct generated in rat liver microsomes in the
presence of 1 M DMAE. B. Dose-dependent effect of DMAE on lipid radical content (), and percentages of inhibition shown by DMAE
supplementation on lipid radical steady state concentration ().
PBN stands for -phenyl-tert-N-butyl-nitrone.
Fig. (3). Scavenging ability of DMAE against OH. A. EPR spectra of DMPO-OH spin adduct, (a) computer simulated spectrum employing as
spectral parameters aN=15 G and aH=15 G; (b) and basal system (in the absence of microsomes); (c) DMPO-OH spin adduct generated in rat
liver microsomes; (d) DMPO-OH spin adduct generated in rat liver microsomes in the presence of 1 M DMAE. B. Dose-dependent effect of
DMAE on OH steady state concentration (), and percentages of inhibition by DMAE supplementation on OH steady state concentration ().
DMPO stands for 5,5-dimethyl-1-pyrroline n-oxide.
10 G
0.0 0.5 1.0 1.5 2.0 2.5
Lipid radical (M)
Inhibition (%)
10 G
0.0 0.5 1.0 1.5 2.0 2.5
Lipid radical (M)
Inhibition (%)
0.0 0.2 0.4 0.6 0.8 1. 0 1.2
Hydroxyl radical (M)
Inhibition (%)
0.0 0.2 0.4 0.6 0.8 1. 0 1.2
Hydroxyl radical (M)
Inhibition (%)
New Insights on Dimethylaminoethanol (DMAE) Drug Metabolism Letters, 2012, Vol. 6, No. 1 57
drug exhibited a maximum in the scavenging activity,
reducing the adduct signal by 87% (Fig. 3A d) in the
presence of 2 M of the substance in comparison with the
control sample without the drug addition, which represents
100% DMPO-OH adduct (Fig. 2A c). Moreover, radical
concentration was significantly decreased as the DMAE
concentration added increased (Fig. 3B). The results
presented here are consistent with the hypothesis that
indicates that OH was efficiently quenched by DMAE
addition, under these experimental conditions.
In Fig. (4A c) is shown the typical ESR spectrum of A
generated in the presence of ascorbic acid and Fe-EDTA,
with the characteristic two lines at g=2.005 and aH+=1.8 G, in
accordance with computer spectral simulated signals (Fig.
4A a), obtained using the parameters stated in the Materials
and Methods section. DMSO itself was examined and no
DMSO spin adduct was observed (Fig. 4A b). A content,
assessed by quantification of EPR signals, was significantly
decreased by the supplementation of increasing amounts of
DMAE (Fig. 4A d). The basic system which represents
100% A content, showed a steady state concentration of A
of (5.9 ± 0.1) 10-2 μM, which was significantly decreased by
DMAE supplementation (Fig. 4B). The results presented
here are consistent with the hypothesis that indicates that A
was efficiently quenched by DMAE, under these experimental
The half-inhibition concentration (IC50) of DMAE, was
calculated from the respective concentration-activity curves
and represents the concentration that gives 50% of the
maximum inhibition of the microsomal lipid radical content,
the OH production rate and the A generation rate. The data
are summarized in Table 1. The relative scavenging capacity
(RSC) represents the number of IC50 per g of DMAE, and
would allow the comparison with the scavenger ability of
other compounds [6]. Data in Table 1 showed the RSC for
each radical species, and strongly suggest that OH is the
most efficiently scavenged species by DMAE among the
tested ones.
Table 1. The IC50 and RSC of DMAE for to the Studied
Radical Species
Radical Species IC50
(IC50/g DMAE)
Lipid radicals 0.4 ± 0.2 8.3
OH 0.26 ± 0.07 41.8
A 0.55 ± 0.06 8.3
IC50 represents the concentration that gives 50% of the maximum inhibition of the
microsomal lipid radical content, or OH production rate, or the A generation rate in
the chemical system.
RSC represents the number of IC50 per g of DMAE.
DMAE, that is available as a nutritional supplement, is a
chemical that have been used to treat a number of conditions
affecting the brain and the central nervous system. It has
been postulated the therapeutic use of this compound for two
major groups of pathologies: i) brain disorders, and ii) aging-
related effects. Preliminary evidence suggests that DMAE
may be helpful for attention deficit hyperactivity disorder
(ADHD) [15, 16]. Unclear results on the effectiveness of
DMAE in the treatment for either Tardive dyskinesia [15-
20], or for Huntington’s chorea disease [15, 21, 22] and
Alzheimer’s disease [17], have been obtained. Thus, widely
marketed as a memory and mood enhancer, and as an agent
to improve intellectual functioning, there is not complete
Fig. (4). Scavenging ability of DMAE against A. A. Electron paramagnetic resonance (EPR) spectra from A, (a) computer simulated
spectrum employing as spectral parameters aH=1.88 G and g=2.0054; (b) basal system (in the absence of ascorbic acid), (c) ascorbic acid 60
μM in DMSO (b); (d) ascorbic acid 60 μM in DMSO and 1 M DMAE. B. Dose-dependent effect of DMAE on A steady state concentration
(), and percentages of inhibition by DMAE supplementation on A steady state concentration ().
DMSO stands for dimethylsulfoxide.
Ascorbyl radical (M)
Inhibition (%)
Ascorbyl radical (M)
Inhibition (%)
Ascorbyl radical (M)
Inhibition (%)
58 Drug Metabolism Letters, 2012, Vol. 6, No. 1 Malanga et al.
agreement among the clinical studies that support its use for
these purposes.
In 1954, Denham Harman proposed a free radical theory
of aging [23]. Today a huge body of evidence confirms that
oxidative stress promotes aging and many seemingly diverse
age-associated diseases [24, 25]. In 1977, the Hungarian
physician Imre Nagy proposed the membrane hypothesis of
aging which posited the cell membrane as the key target of
free radical activity and which has been confirmed
experimentally [26-29]. Also it was shown that higher levels
of oxygen predispose membranes to produce ROS that attack
and easily oxidized the polyunsaturated fatty acids (PUFA)
in the lipid bi-layers, producing an inflammatory cascade
that causes cellular damage and senescence [30, 31].
Although aging is a natural phenomenon and bodily decay is
an inexorable process, aging can at least be postponed or
prevented by certain approaches [1]. DMAE has powerful
anti-inflammatory effects when applied to skin, and with the
proper carrier it increases underlying muscle tone showing
acute and cumulative effects [32].
There is some controversy about the action mechanisms
proposed for DMAE effects [2-8, 15, 17, 33]. Moreover,
Nagy and Floyd (1984) [32] have shown in an in vitro study
that DMAE was a competitive OH scavenger, supporting a
molecular mechanism for the anti-aging effects of DMAE in
terms of the membrane hypothesis of aging. More recently,
Gragnani et al. [34] have shown that DMAE reduced the
proliferation of fibroblasts, increased cytosolic Ca and
changed the cell cycle, causing an increase in apoptosis
(cellular death associated to free radical production) in
human fibroblasts. Thus, a basic analysis employing a
specific technique such as EPR, was employed to assess the
ability of the compound to scavenge radicals responsible for
producing damage in the water phase (such as OH and A)
and in the lipid phase (such as lipid radicals), comparatively.
The data presented here clearly showed that DMAE
efficiently scavenges all the radical species tested. However,
the comparison of the IC50 indicated that the efficiency is
not identical in the lipo- and hydrophilic phases. By the
direct comparison of the IC50 (Table 1) for the radical
species tested it is concluded that DMAE the best scavenger
capacity towards OH (87% inhibition) and A (79%
inhibition) as compared to lipid radicals (44% inhibition).
Thus, DMAE seems as a better scavenger for radicals
generated in the hydrophilic milieu, with a relative lower
ability for the scavenging of lipid radicals.
It was suggested that EGb is a scavenger of peroxyl
radicals generated in both lipid and aqueous environments
[35], through indirect measurements, and EPR studies [6].
Kose and Dogan [36] have shown that EGb extracts have
more antioxidant potential than water-soluble antioxidants
(ascorbic acid, glutathione and uric acid); and was as effective
as lipid-soluble antioxidants (alpha-tocopherol and retinol
acetate) in protecting red-cell suspensions against lipid
peroxidation induced by H2O2. The RSC of EGb towards
lipid radicals was 862 AU [6], being almost two orders of
magnitude higher than the RSC reported here for DMAE.
This observation is consistent with the lack of effect on
TBARS content in the microsomes after the addition of
DMAE, under the tested experimental conditions. The RSC
of EGb towards OH was 260 AU [6], being six-fold higher
than the RSC reported here for DMAE. As EGb is a mixture
of different chemical constituents, its scavenging activity
could be due to a particular component as well as to the
interactions of different antioxidant molecules, and the
component responsible for its scavenging properties could
not be specifically identified. Further, the membrane-stabilizing
action of EGb 761 has been previously demonstrated, since it
decreased the osmotic fragility of rat erythrocytes and
penetrated into membrane phospholipid domain [14]. Besides
Ginkgoflavone glycosides and terpenoids, the extract also
contains other substances of minor interest, such as organic
acids, which would play a role in its water solubility. Thus,
EGb extracts would be able to show both lipophilic and
hydrophilic characteristics. Moreover, Deby and Pincemail
[37] have suggested that polyphenolic substances in EGb
extract play a protective role at another level, since during
their transformation into quinone, they can give up two
hydrogen atoms and their electron to lipoperoxides. DMAE,
that shares with EGb the characteristic of improving brain
alert and focus [38], has only one hydroxyl group with
possible antioxidant ability suggesting that other mechanism
should contribute to explain the observed effects of DMAE.
However, the role of DMAE in dermatology including a
potential anti-inflammatory effect and a documented
increase in skin firmness with possible improvement in
underlying facial muscle tone [39] could be a conjunction of
many actions including its antioxidant activity. On the other
hand, the incorporation of chemical compounds into the cell
is a function of their lipophilicity. Thus, the antioxidant
activity of extracts appears to be dictated not only by the
structural features but also by their location in the membranes.
The small size of this molecule could be a positive factor to
get access to protect cellular targets against free radical
damage. The results presents here might be taken into
consideration for further biotechnological developments
of protective antioxidants, which could have important
applications in human diseases accompanied by free radical
injury. Any biologically active compound should appear in
the target tissues in significant amounts to elicit bioprotective
effects. Future studies should consider interactions of
the supplemented compound with endogenous antioxidants,
as well as tissue specificity, compartmentalization and
concentration levels of the active compound/s in target
organs, to appropriately assess effectiveness in vivo.
Declared none.
This study was supported by grants from the University
of Buenos Aires, and CONICET. S.P. and G.M. are career
investigator from CONICET. M.B.A. is a fellow from
BHT = Butylated hydroxytoluene
DMPO = 5,5-dimethyl-1-pyrroline n-oxide
DTPA = Diethylenetriaminepentaacetic acid
New Insights on Dimethylaminoethanol (DMAE) Drug Metabolism Letters, 2012, Vol. 6, No. 1 59
[1] Kapoor, V.K.; Dureja, J.; Chadha, R. Synthetic drugs with anti-
ageing effects. Drug Discov. Today, 2009, 14, 899-904.
[2] Leon Oettinger Jr., M.D. The use of deanol in the treatment of
disorders of behavior in children. J. Pediatr., 1958, 53(6), 671-675.
[3] Pathak, M.A. Topical and systemic approaches for protection of
human skin against harmful effects of solar radiation. J. Am. Acad.
Dermatol., 1982, 7, 285-312.
[4] Uhoda, I.; Faska, N.; Robert, C.; Cauwenbergh, G.; Piérard,
G.E. Split face study on the cutaneous tensile effect of 2-
dimethylaminoethanol (deanol) gel. Skin Res. Technol., 2002, 8(3),
[5] Puntarulo, S.; Cederbaum, A.I.; Comparison of the ability of the
ferric complexes to catalyze microsomal chemiluminescence, lipid
peroxidation and hydroxyl radical generation. Arch. Biochem.
Biophys., 1988, 264, 482-491.
[6] Boveris, A.D.; Puntarulo, S. Free-radical scavenging actions of
natural antioxidants. Nutr. Res., 1998, 18, 1545-1557.
[7] Boveris, A.D.; Galatro, A.; Puntarulo, S. Effect of nitric oxide and
plant antioxidants on microsomal content of lipid radicals. Biol.
Res., 2000, 33, 159-165.
[8] Jurkiewicz, B.A.; Buettner, G.R. Ultraviolet light-induced free
radical formation in skin: an electron paramagnetic resonance
study. Photochem. Photobiol., 1994, 59, 1-4.
[9] Kotake,Y.; Tanigawa, T.; Tanigawa, M.; Ueno, I.; Allen, D.R.; Lai,
C. Continous monitoring of cellular nitric oxide generation by spin
trapping with an iron-dithiocarbamate complex. Biochim. Biophys.
Acta, 1996, 1289, 362-368.
[10] Green, M.J., Hill, H.A. Chemistry of dioxygen. Meth. Enzymol.,
1984, 105, 3-22.
[11] McCay, P.B.; Reinke, L.A.; Rau, J.M. Hydroxyl radicals are
generated by hepatic microsomes during NADPH oxidation:
relationship to thenol metabolism. Free Radic. Res. Comm., 1992,
15, 335-346.
[12] Giulivi, C.; Cadenas, E. The reaction of ascorbic acid with different
heme iron redox states of myoglobin. FEBS Lett., 1993, 332,
[13] Buettner, G.R. Spin trapping: ESR parameters of spin adducts.
Free Radic. Biol. Med., 1987, 3, 259-303.
[14] Etienne, A.; Hecquet, F.; Clostre, F. Comparison des effects d’un
extrail de Gingko biloba et de la chor-promazine sur la fragilité
osmotique, in vitro, d’erytrocutes de rat. J. Pharmacol., 1982, 13,
[15] Re', O. 2-Dimethylaminoethanol (deanol): a brief review of its
clinical efficacy and postulated mechanism of action. Curr. Ther.
Res. Clin. Exp., 1974, 16, 1238-1242.
[16] Knobel, M. Approach to a combined pharmacologic therapy of
childhood hyperkinesis. Behav. Neuropsychiatry, 1974 Apr-1975
Mar, 6, 87-90.
[17] Fisman, M.; Mersky, H.; Helmes, E. Double-blind trial of 2-
dimethylaminoethanol in Alzheimer's disease. Am. J. Psychiat.,
1981, 138, 970-972.
[18] Casey, D.E.; Denney, D. Dimethylaminoethanol in tardive
dyskinesia [letter]. N. Engl. J. Med., 1974, 291, 797.
[19] Alphs, L.; Davis, J.M. Noncatecholaminergic treatments of tardive
dyskinesia. J. Clin. Psychopharmacol., 1982, 2, 380-385.
[20] Soares, K.V.; McGrath, J.J. The treatment of tardive dyskinesia - a
systematic review and meta-analysis. Schizophr. Res., 1999, 39, 1-18.
[21] Caraceni, T.A.; Girotti, F.; Celano, I. 2-dimethylaminoethanol
(deanol) in Huntington's chorea. J. Neurol. Neurosurg. Psychiat.,
1978, 41, 1114-1118.
[22] Tarsy, D.; Bralower, M. Deanol acetamidobenzoate treatment in
choreiform movement disorders. Arch. Neurol., 1977, 34, 756-758.
[23] Harman, D. Nutritional implications of the free-radical theory of
aging. J. Am. Coll. Nutr., 1982, 1(1), 27-34.
[24] Vendemiale, G.; Grattagliano, I; Altomare. E. An update on the
role of free radicals and antioxidant defense in human disease. Int.
J. Clin. Lab. Res., 1999, 29(2), 49-55.
[25] Toyokumi, S. Reactive oxygen species-included molecular damage
and its application in pathology. Phatol. Int., 1999, 49(2), 91-102.
[26] Zs-Nagy, I. The membrane structure and function in cellular aging:
a review. Mech. Aging Dev., 1979, 9(3-4), 237-246.
[27] Terman, A. Garbage catastrophe theory of aging: imperfect
removal of oxidative damage? Redox Rep., 2001, 1, 15-26.
[28] Zs-Nagy, I. The membrane hypothesis of aging: its relevance to
recent progress in genetic research. J. Mol. Med., 1997, 75(10),
[29] Zs-Nagy, I.; Semsei, I. Centrophenoxine increases the rates of total
and mRNA synthesis in the brain cortex of old rats: an explanation
of its action in terms of the membrane hypothesis of aging. Exp.
Gerontol., 1984, 9(3), 171-178.
[30] Wilhelm, J. Metabolic aspects of membrane lipid peroxidation.
Acta Univ. Carol Med. Monogr., 1990, 137, 1-53.
[31] Spiteller, G. Peroxidation of linolic acid and its relation to aging
and age dependent diseases. Review. Mech. Ageing Dev., 2001,
122(7), 617-657.
[32] Zs-Nagy, I.; Floyd, R.A. Electron spin resonance spectroscopic
demonstration of the hydroxyl free radical scavenger properties of
dimethylaminoethanol in spin trapping experiments conforming the
molecular basis for the biological effects of centrophenoxine. Arch.
Gerontol Geriatr., 1984, 3(4), 297-310.
[33] Zahniser, N.R.; Chou, D.; Hanin, I. Is 2-dimthylaminoethanol
(deanol) indeed a precursor of brain acetylcholine? A gas
chromatographic evaluation. J. Pharmacol. Exp. Ther., 1977, 200,
[34] Gragnani, A.; Giannoccaro, F.B.; Moraes, A.A.; Franca, J.P.;
Ferreira, A.T.; Ferreira, L.M. Dimethylaminoethanol affects
viability of human cultured fibroblasts. Aesthetic. Plast. Surg.,
2007, 31(6), 711-718.
[35] Maitra, I.; Marcci, L.; Droy-Lefaix, M.T.; Packer, L. Peroxyl
radical scavenging activity of Gingko biloba extract EGb 761.
Biochem. Pharmacol., 1995, 49, 1649-1655.
[36] Kose, K.; Dogan, P. Lipoperoxidation induced by hydrogen
peroxide in human erytrocyt membranes. 2. Comparison of the
antioxidant effect of Gingko biloba extract (EGb 761) with those of
water-soluble and lipid antioxidants. J. Inter. Med Res., 1995, 23,
[37] Deby, C.; Pincernail, J. In: Rokan (Gingko biloba) Recent results in
pharmacology and clinic; Funfgeld F.W., Ed.; Springer Verlag
Berlin Heidelberg New York, 1988; 57-70.
[38] Mix, J.A.; Crews, W.D. A double-lind, placebo controlled,
randomized trial of Ginkgo Biloba extract EGb 761 in a sample of
cognitibily intact older adults: neuropsychological findings. Human
Psychopharmacol. Clin. Exp., 2002, 17, 267-277.
[39] Grossman, R. The role of dimethylaminoethanol in cosmetic
dermatology. Am. J. Clin. Derm., 2005, 6(9), 39-37.
Received: September 28, 20 11 Revised: November 29, 2011 Accepted: December 22, 20 11
... Additionally, it was proved that DMAE administration does not alter the tissue levels and excretion of choline. Malanga et al. (2012) investigated the role of DMAE as antioxidant through the analysis of the capacity of DMAE to inhibit rat liver microsomal NADPH-dependent lipid peroxidation as well as the generation of hydroxyl radical and ascorbyl radical by Electron Spectroscopic Resonance (EPR). DMAE significantly reduced the formation of the radical intermediates of lipid peroxidation and hydrophilic radicals in comparison to the control samples without DMAE addition in a dose dependent manner. ...
... Overall, the studies by Malanga et al. (2012) and Ait-Ghezala et al. (2016) provide further details on the mechanism of action of DMAE, yet reporting no evidence of genotoxic potential. ...
Full-text available
Following a request from the European Commission, the Panel on Additives and Products or Substances used in Animal Feed (FEEDAP) was asked to deliver a scientific opinion on the assessment of the application for renewal of authorisation of the feed additive consisting of dimethylglycine sodium salt (trade name: Taminizer D) as a zootechnical additive for chickens for fattening. In 2011, the FEEDAP Panel delivered an opinion on the safety and efficacy of the additive, and subsequently, the additive was authorised in the EU. In 2018, a second scientific assessment was made based on a dossier submitted for the modification of the terms of authorisation of the additive. The additive is authorised as 'dimethylglycine sodium salt with a purity of at least 97%' for chickens for fattening under the category 'zootechnical additives' and functional group 'other zootechnical additives (improvement of zootechnical parameters)'. The evidence provided by the applicant indicated that the additive currently in the market, produced by the two manufacturing routes, complies with the conditions of authorisation. No new evidence was found that would make the FEEDAP Panel reconsidering its previous conclusions in the safety for target species, consumers and environment. The FEEDAP Panel concludes that Taminizer D is not a skin irritant but may be an eye irritant and a skin sensitiser; although uncertainty remains on the presence of formaldehyde, exposure is considered extremely low. There is no need to assess the efficacy of the additive in the context of the renewal of the authorisation.
... The strong interest of the food industry is related to its nutritional content, such as proteins, unsaturated fatty acids [11], vitamins, and minerals, which makes caviar to be considered for cosmetic purposes as well [12,13]. Also occurring in fish like sardines and salmon, dimethylaminoethanol (DMAE) is a substance frequently used with antiaging appeal due to several possible mechanisms that are constantly investigated [14][15][16][17]. Within this scenario, besides the need to invest in natural raw materials, cosmetic product developers are more than ever investing in new sensory technologies to survive in this competitive market. ...
Full-text available
Abstract The high consumption of antiaging cosmetics represents an outstanding opportunity for the development of new processes and attractive products in the cosmetic industry. Stability studies and sensory analyses are critical steps in the development process and production chain. Here we present a potential antiaging cosmetic product with innovative sensory characteristics. Caviar extract antioxidant properties were firstly evaluated by the DPPH method since it is an important mechanism against skin aging. Ca-alginate beads containing 2% of caviar extract and 0.2% of black pigment were prepared to obtain spheres similar to caviar. The beads were incorporated in a gel phase (hydroxyethylcellulose 2.5%) containing 3% of dimethylaminoethanol. Stability was evaluated in different storage conditions (sunlight exposure, 5 ± 2 °C, 37 ± 2 °C and r.t.) through the parameters: appearance, color and odor, pH (6-7), density (0.98-1.14 g.mL-1), centrifugation and average size. After approval by the Committee for Ethics in Research (n° 3.503.061), 30 volunteers tested the new formulation and answered a questionnaire. At 2%, caviar extract was able to scavenge 10.9% ± 0.58 of DPPH radical. Formulations showed good stability after 90 days, even considering the average size (7.47 ± 0.41 - 8.4 ± 0.65 mm2). 90% of the sensory test participants reported that they would buy the new product. Therefore, the new product developed demonstrates a promising potential as an attractive cosmetic product.
... В качестве потенциальных средств с актопротекторной активностью большой интерес представляют производные аминоэтанола ( этаноламина), обладающие широким спектром фармакологической активности, в т. ч. в отношении умственной и физической работоспособности [6,9]. Поскольку фармакологическая коррекция процессов умственного и физического утомления имеет ряд общих принципов, то соединения, обладающие ноотропным и антиоксидантным действием, перспективны для изучения в качестве актопротекторов [11,16,20]. ...
Full-text available
The article presents the results of evaluation of actoprotective activity of combined dimethylaminoethanol compounds containing intermediates of the citric acid cycle (L-malate, α-ketoglutarate, succinate and fumarate). The effect of long-term intragastric administration of pharmacological agents for 4 weeks at a dose of 75 mg/kg on the static, dynamic endurance, motor coordination and body weight gain of “trained” laboratory animals was assessed in comparison with reference actoprotector ethylthiobenzimidazole (25 mg/kg, intragastrically). It was found that the most promising substances for further study are alpha-ketoglutarate and succinate compounds. After 1 month of training, dynamic endurance and coordination of movements were most influenced by DMAE-malate (increase by 60%, p=0.011), static endurance was increased during the 2nd week by DMAE-malate (by 16%, p=0.005) and DMAE-ketoglutarate (by 15.8%, p=0.006), on the 4th week – DMAE-ketoglutarate (by 19.7%, p=0.0001) and DMAE-succinate (by 12.2%, p=0.003). A pronounced body weight increase was observed in the group receiving DMAE-ketoglutarate (by 29%, p=0.022). In general, combined compounds of dimethylaminoethanol with alpha-ketoglutarate, malate and succinate showed the highest actoprotective activity.
... Posttreatment of centrophenoxine after aluminum exposure significantly reduced the lipid peroxidation levels and increased the reduced glutathione content in the rat brain's cerebrum and cerebellum (Nehru et al. 2007). The ability to scavenge specific free radicals was confirmed for DMAE with electron spectroscopic resonance (Malanga et al. 2012). ...
... After ingestion and absorption into the bloodstream, DMAE crosses the blood-brain barrier and becomes a precursor of acetylcholine in the CNS. [47,185] DMAE in the form of salts or esters has long been used as a component of many therapeutic agents. The preparation containing this structure, i. e., Centrophenoxin, was used in geriatrics, particularly in patients with dementia or stroke. ...
... After ingestion and absorption into the bloodstream, DMAE crosses the blood-brain barrier and becomes a precursor of acetylcholine in the CNS. [47,185] DMAE in the form of salts or esters has long been used as a component of many therapeutic agents. The preparation containing this structure, i. e., Centrophenoxin, was used in geriatrics, particularly in patients with dementia or stroke. ...
This review focuses on four new product categories of food supplements: pre‐workout, fat burner/thermogenic, brain/cognitive booster, and hormone/testosterone booster. Many food supplements have been shown to be contaminated with unauthorized substances. In some cases, the ingredients in the new categories of dietary supplements were medicinal products or new synthetic compounds added without performing clinical trials. Some of the new ingredients in dietary supplements are plant materials that are registered in the pharmacopoeia as herbal medicines. In other cases, dietary supplements may contain plant materials that have no history of human use and are often used as materials to “camouflage” stimulants. In the European Union, new ingredients of dietary supplements, according to European Food Safety Authority or unauthorized novel food. Furthermore, selected ingredients in dietary supplements may be prohibited in sports and are recognized as doping agents by World Anti‐Doping Agency.
... Публикации, посвященные изучению производных диметилэтаноламина и его солей Publications devoted to the study of dimethylethanolamine derivatives and its salts 1946 1954 1960 1965 1970 1975 1980 1985 1990 1995 • уменьшения процессов перекисного окисления липидов (ПОЛ) за счет снижения образования малонового диальдегида, лизофосфолипидов, повышения активности супероксиддисмутазы и уровня восстановленного глутатиона в тканях. Кроме того, ДМЭА может выступать в качестве «скэвенжера» свободных радикалов [11]. ...
Full-text available
Introduction. Central nervous system (CNS) diseases lead to severe disorders that dramatically reduce the standard of living in patients and have a high social significance. This determines the relevance of a search for novel drugs for the pharmacological protection of the brain in various CNS injuries. Of great interest are ethanolamine derivatives, especially dimethylethanolamine (DMEA) salts and esters, which are actively used in neurological practice to treat various CNS diseases. Ethanolamine derivatives are able to facilitate the synthesis of acetylcholine and phosphatidylcholine in neuronal membranes, to stimulate cholinergic neurotransmission, and to improve the plasticity of neuronal membranes. This leads to the increases in the ability to concentrate, memorize, and reproduce the information received; to the optimization of cognitive and behavioral reactions; and to the reductions in neurological deficit and emotional instability. This review considers ethanolamine derivatives and salts used in clinical practice, their pharmacological characteristics, and possible side effects. Objective: to systematize and update the existing information about ethanolamine derivatives and salts as promising neuroprotective agents. Conclusion. Ethanolamine derivatives as neuroprotective agents develop their effects gradually when administered for weeks or even months. As compared with the available neuroprotective and nootropic agents, ethanolamine derivatives demonstrate no less efficiency, in this case showing a high safety profile. These compounds may be used to treat CNS diseases characterized by degenerative, traumatic or vascular lesions, conditions accompanied by hypoxia and/or decreased physical performance, as well as cognitive impairment.
This article presents the results of assessing the effect of course administration of dimethylaminoethanol derivatives in various modes on the static and dynamic endurance of small laboratory animals during training loads. It was found that ketoglutarate has the greatest effect on the static physical endurance of animals, while malate — on the dynamic physical endurance.
This review analyzed the literature data on the in vitro preclinical study of the cytotoxic properties of organotin compounds, as well as the main mechanisms of their action. The latter consist in interacting with SH groups of proteins, initiating oxidative stress, binding to DNA, interacting with receptors, as well as activate apoptosis by increasing the expression of caspases, proapoptotic proteins, and decreasing antiapoptotic proteins. Organotin compounds, depending on the donor ligand, exhibit specifi c cytotoxicity towards certain tumor cell lines. The high cytotoxic potential indicates the possibility of further development in vivo and research of organotin compounds as candidates for the creation of drugs for anticancer and antimetastatic therapy.
The role of polymorphs in understanding and controlling the crystallization process from solution for an organic acid-base system is reported. Herein, the crystallization process of dimethylethanolammonium 4-nitrobenzoate (DMEA4NB) is explored by different pathways of crystallization, using 4-nitrobenzoic acid polymorphs crystallized in different space groups: monoclinic P21/n (4NBH), respectively C2/c (4NBH*). The crystal growth process was investigated by complementary experimental techniques such as single crystal and powder X-ray diffraction, Fourier transform infrared spectroscopy, hot-stage optical microscopy and thermogravimetric analysis correlated with ab initio computational study. The experimental and theoretical data revealed that 4NBH is more stable with respect to 4NBH*, indicating that 4NBH* is more favorable for one-step crystal growth process, while 4NBH polymorph leads to DMEA4NB formation through three intermediate phases. The changes over time associated with solid-solid phase transformations in the crystal growth process are evaluated. The opacification process of DMEA4NB has indicated a partially reversible transformation of the product to an intermediate phase.
It has been suggested that ultraviolet light induces free radical formation in skin, leading to photoaging and cancer. We have demonstrated by electron paramagnetic resonance that the ascorbate free radical is naturally present in unexposed skin at a very low steady state level. When a section of SKH-1 hairless mouse skin in an EPR cavity is exposed to UV light (4,500 J m−2−1, Xe lamp, 305 nm cutoff and IR filters), the ascorbate free radical signal intensity increases. These results indicate that UV light increases free radical oxidative stress, consistent with ascorbate's role as the terminal, small-molecule antioxidant. The initial radicals produced by UV light would have very short lifetimes at room temperature; thus, we have applied EPR spin trapping techniques to detect these radicals. Using α-[4-pyridyl 1-oxide]-N-tert-butyl nitrone (POBN), we have for the first time spin trapped a UV light-produced carbon-centered free radical from intact skin. The EPR spectra exhibited hyperfine splittings that are characteristic of POBN/alkyl radicals, aN= 15.56 G and aH= 2.70 G, possibly generated from membrane lipids as a result of β-scission of lipid alkoxyl radicals. Iron can act as a catalyst for free radical oxidative reactions; chronic exposure of skin to UV radiation causes increased iron deposition. Using our spin trapping system, we have shown that topical application of the iron-chelator, Desferal, to a section of skin reduces the UV light-induced POBN adduct radical signal. These results provide direct evidence for free radical generation and a role for iron in UV light-induced dermatopathology. We suggest that iron chelators can serve as photoprotective agents by preventing these oxidations.
A dose-dependent inhibitory effect of wheat, alfalfa and ginkgo biloba (EGb) extracts on TBARS production was measured. The half-inhibition concentration (IC50) of the tested antioxidants were 2.7±0.2, 1.3±0.1, and 0.20±0.02 mg/ml for wheat, alfalfa and EGb extracts, respectively. Lipid radicals combined with the spin trap POBN resulted in adducts that gave a characteristic EPR spectrum. The IC50 of the tested antioxidants on lipid radical content, were 12.4±0.2, 7.7±0.3, and 1.20±0.06 mg/ml for wheat, alfalfa and EGb extracts, respectively. Rat liver microsomes in the presence of DMPO, NADPH and iron-citrate generate an EPR spectra with characteristics of the DMPO-OH spin adduct. The basic system, without the addition of any scavenger showed an area of 3.5 AU/mg protein. The areas in the presence of 1.5 mg/ml EGb, 4 mg/ml wheat or alfalfa, were of 1.7±0.2, 3.4±0.3, and 3.6±0.2 AU/mg protein, respectively. O2− generation rate by the microsomes exposed to EGb extract was decreased by 40%, as compared to the rate measured in microsomes incubated in the absence of the extract. However, the supplementation of rat liver microsomes with either wheat or alfalfa extracts did not affect microsomal generation of O2−. Iron reduction rate was not affected by the addition of any of the tested extracts. The data presented here showed that EGb extracts were able to limit lipid peroxidation and scavenge lipid radicals in rat liver microsomes more efficiently than alfalfa and wheat bran extracts. Moreover, wheat and alfalfa extracts were not able to inhibit O2− and ·OH generation by biological membranes, suggesting that their potentiality to be successfully used in human health in the treatment of diseases involving free radical and oxidative damage are not as promising as that for the use of EGb extracts.
Antioxidant mechanisms have been proposed to underlie the beneficial pharmacological effects of EGb 761, an extract from Ginkgo biloba leaves used for treating peripheral vascular diseases and cerebrovascular insufficiency in the elderly. In vitro evidence has been reported that EGb 761 scavenges various reactive oxygen species, i.e. nitric oxide, and the Superoxide, hydroxyl, and oxoferryl radicals. However, the ability of EGb 761 to scavenge peroxyl radicals (reactive species mainly involved in the propagation step of lipid peroxidation) has not been investigated. To characterize further the antioxidant action of EGb 761, we measured the protective effects of EGb 761 during: (1) the oxidation of B-phycoerythrin by peroxyl radicals generated in aqueous solution by 2,2′-azobis (2-amidinopropane) hydrochloride (AAPH); and (2) the reaction of luminol or cis-parinaric acid with peroxyl radicals generated from 2,2′-azobis (2,4-dimethylvaleronitrile) (AMVN) in liposomes or in human low density lipoprotein (LDL), respectively. To evaluate the peroxyl radical scavenging activity of EGb 761 in a more physiologically relevant model of damage to lipid-containing systems, we also analyzed the effect of the extract on the oxidation of human LDL exposed to the azo-initiators in terms of: (1) accumulation of cholesterol linoleate ester hydroperoxides, (2) depletion of α-tocopherol and β-carotene, and (3) changes in intrinsic tryptophan fluorescence. EGb 761 afforded protection against oxidative damage in all the systems we analyzed; thus, it is an efficient scavenger of peroxyl radicals. This result extends the oxygen radical scavenging properties of the extract and supports the hypothesis of an antioxidant therapeutic action of EGb 761.
The interaction of microsomes with iron and NADPH to generate active oxygen radicals was determined by assaying for low level chemiluminescence. The ability of several ferric complexes to catalyze light emission was compared to their effect on microsomal lipid peroxidation or hydroxyl radical generation. In the absence of added iron, microsomal light emission was very low; chemiluminescence could be enhanced by several cycles of freeze-thawing of the microsomes. The addition of ferric ammonium sulfate, ferric-citrate, or ferric-ADP produced an increase in chemiluminescence, whereas ferric-EDTA or -diethylenetriaminepentaacetic acid (detapac) were inhibitory. The same response to these ferric complexes was found when assaying for malondialdehyde as an index of microsomal lipid peroxidation. In contrast, hydroxyl radical generation, assessed as oxidation of chemical scavengers, was significantly enhanced in the presence of ferric-EDTA and -detapac and only weakly elevated by the other ferric complexes. Ferric-desferrioxamine was essentially inert in catalyzing any of these reactions. Chemiluminescence and lipid peroxidation were not affected by Superoxide dismutase, catalase, or competitive hydroxyl radical scavengers whereas hydroxyl radical production was decreased by the latter two but not by Superoxide dismutase. Chemiluminescence was decreased by the antioxidants propylgallate or glutathione and by inhibiting NADPH-cytochrome P-450 reductase with copper, but was not inhibited by metyrapone or carbon monoxide. The similar pattern exhibited by ferric complexes on microsomal light emission and lipid peroxidation, and the same response of both processes to radical scavenging agents, suggests a close association between chemiluminescence and lipid peroxidation, whereas both processes can be readily dissociated from free hydroxyl radical generation by microsomes.
Although ageing is a natural wear and tear phenomenon, it can at least be postponed or prevented by certain approaches. Some chemicals that are present in the diet or in dietary supplements have been documented to have anti-ageing effects. Recently, a number of synthetic drugs used for other therapeutic indications have been shown to have anti-ageing potential.
Deanol acetamidobenzoate was administered in double-blind, crossover fashion with placebo to five patients with tardive dyskinesia, three patients with Huntington's chorea, and one patient with posthemiplegic chorea. No significant effect on dyskinesia was observed. Preliminary administration of physostigmine salicylate to patients with tardive dyskinesia had a variable effect, while benztropine mesylate produced no change. Since the status of deanol as an effective precursor of acetylcholine is uncertain, further trials with putative cholinergic agents remain warranted in choreiform syndromes.
A double-blind crossover trial with 2-dimethylaminoethanol (Deanol), a possible precursor of brain acetylcholine, was carried out in nine patients with Huntington's chorea. It was found to be ineffective in inducing any alteration in hyperkinesia.
A survey of the available theoretical and experimental evidence is given regarding the cell membrane properties, such as the membrane fluidity, potassium permeability, etc., which are involved in the regulation of intracellular ion contents. These properties of the membrane undergo some age-dependent alterations in numerous cells studied so far, resulting in an increase of the intracellular potassium content. This phenomenon has a serious inhibitory effect on the rates of enzymatic catalyses involved in the protein synthesis, and may explain the decreased protein synthetic capacity of the old cells. Data are presented indicating that some changes in the membrane permeability are also involved in the malignant transformation of the cells; however, these are of opposite direction as compared to aging of cells. The "membrane hypothesis" of aging based on these facts seems to be a useful experimental approach to the problem of cellular aging.
Acute administration of deanol-p-acetamidobenzoate (Deaner; deanol) has been reported to elevate brain choline (CH) and acetylcholine (ACh) levels. We have developed a specific and sensitive gas chromatographic assay to measure deanol levels in tissue and have applied this assay to our studies of the effect of acute deanol administration on deanol, ACh and Ch levels in rodent brains. Details of the method are described in this text. This procedure is quantitative and yields reproducible results over a wide range of deanol concentrations (0.30-200 nmol). Seven endogenous and pharmacological parameters have been studied using this procedure. In control rodent brain, liver, heart, lung and plasma, we detected no free endogenous deanol (less than 1 nmol/g). After deanol administration, we were able to detect deanol in tissue and have attempted to determine a relationship between these levels and values of ACh in the same tissue. Regardless of deanol pretreatment time (1-30 minutes) or doses (33.3-3000 mg/kg i.p.) used, we detected no increase in mouse whole brain ACh levels. Likewise, there was no detectable elevation in ACh levels in rat whole brain, cortex, striatum or hippocampus after a 15-minute pretreatment with 550 mg/kg of deanol (i.p.). The only elevation in ACh levels which we detected occurred selectively in the striatum of mice pretreated with a massive dose (900 mg/kg i.p.) of deanol for 30 minutes. This selective increase in striatal ACh levels oculd not, however, be related to levels of deanol in the striatum because there was no greater accumulation of deanol in the striatum than in other brain areas tested or in whole brain. These data do not confirm the results of other investigators who reported elevations in whole brain or striatal ACh levels after acute administration of lower doses of deanol. The data emphasize the need for further investigation into the mode of action of deanol and question its suggested role as an immediate precursor of ACh synthesis in the central nervous system.